Zealand Pharma A/S (22Z F) stock market data APIs
€53.9424
-0.77(-1.4%)
as of February 6, 2026
Try our APIs with
free plan!
Zealand Pharma A/S Financial Data Overview
Price chart is built with
Anychart
Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States. The company has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. It also provides Zegalogue, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon for treating congenital hyperinsulinism. In addition, the company developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. Zealand Pharma A/S was incorporated in 1997 and is based in Søborg, Denmark.
Prev. Close
53.9424
Open
53.1735
High
54.2571
Low
53.1557
52 wk Range
41.45-106.2
Market Cap
3 775 M
P/E Ratio
4.3827
Shares Outstanding
70 437 K
Revenue
9 155 M
Beta
0.48
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Zealand Pharma A/S data using free add-ons & libraries
Get Zealand Pharma A/S Fundamental Data
Zealand Pharma A/S Fundamental data includes:
- Net Revenue: 9 155 M
- EBITDA: 7 081 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Zealand Pharma A/S News
New
AstraZeneca Strikes Obesity Multibillion-Dollar Deal With China’s CSPC Pharmaceuticals
The agreement to gain rights outside of China to a portfolio of early-stage experimental obesity and diabetes drugs could be valued at billions of dollars. Continue Reading
Roche Obesity Shot Helps Patients Lose Weight in Midstage Trial
Roche Holding said an experimental injection achieved positive results in a midstage clinical trial by helping patients shed weight, paving the way for the start of the company’s first late-stage ob...
Assessing Zealand Pharma (CPSE:ZEAL) Valuation After Prolonged Share Price Weakness
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Why Zealand Pharma stock is on investors’ radar Zealand Pharma (CPSE:ZEAL) h...
Strength Seen in Zealand Pharma AS (ZLDPF): Can Its 6.8% Jump Turn into More Strength?
Zealand Pharma A/S (ZLDPF) shares rallied 6.8% in the last trading session to close at $67.8. This move can be attributable to notable volume with a higher number of shares being traded than in a typi...
Get Zealand Pharma A/S fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
